Lexby WheresMyMEPGet Pro free

OM Pharma SA has 14 disclosed EU lobbying meetings from 2024-10-15 to 2026-05-13: 1 with the European Commission and 13 with Members of the European Parliament. Source: EU Transparency Register no. 212362053240-64, Commission disclosures and MEP declarations. Methodology

OM Pharma SA

EU lobbying footprint — who they meet, and on what.

Register no.
212362053240-64 ↗
Disclosed meetings
14 (1 Commission · 13 MEP)
Period
2024-10-15 → 2026-05-13

Declared fields of interest: Climate action · Education and training · Public health · Research and innovation

Lobbying profile

as declared 2026-02-19
Category
Companies & groups
Legal status
Ltd. Company
Declared lobbying cost
€200,000
Lobbying FTEs
0.85
LobbyFacts / Transparency Register source ↗

At a glance

Most-met policy areas
  • Biotech Act1
  • Health Policy1
  • AMR1
  • Introductory Meeting1
  • Exchange of Views1
Commission officials
  • Jana Dabbelt1

Disclosed meetings

Newest first. EC = European Commission, EP = Member of the European Parliament.

Frequently asked

How many EU lobbying meetings has OM Pharma SA disclosed?

OM Pharma SA (EU Transparency Register no. 212362053240-64) appears in 14 disclosed meetings with EU officials and MEPs between 2024-10-15 and 2026-05-13: 1 with the European Commission and 13 with Members of the European Parliament.

What does OM Pharma SA lobby on?

OM Pharma SA's disclosed EU meetings most often concern Biotech Act, Health Policy, AMR, Introductory Meeting. Every meeting and its topic is listed with its official source on this page.

Who does OM Pharma SA meet in Brussels?

Across its disclosed meetings, OM Pharma SA has met Commission officials including Jana Dabbelt, and MEPs including BOSSE Stine, SOKOL Tomislav, NEVADO DEL CAMPO Elena. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See how this affects your company →Ask Lex about OM Pharma SA →